1. Serum Inflammation-based Scores in Endocrine Tumors
    Pedro Marques et al, 2021, The Journal of Clinical Endocrinology & Metabolism CrossRef
  2. Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies
    Gitta Boons et al, 2019, Reviews in Endocrine and Metabolic Disorders CrossRef
  3. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
    Massimo Milione et al, 2019, The Journal of Pathology: Clinical Research CrossRef
  4. The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms
    Shuaishuai Xu et al, 2022, Cancers CrossRef
  5. Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
    Fei Wang et al, 2021, Frontiers in Endocrinology CrossRef
  6. Defining Tumor Microenvironment as a Possible Target for Effective GEP-NENs Immunotherapy—A Systematic Review
    Paulina Chmiel et al, 2023, Cancers CrossRef
  7. CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors
    Masami Miki et al, 2019, Cancer Medicine CrossRef
  8. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs)
    Lei Cai et al, 2019, Clinical Cancer Research CrossRef
  9. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee et al, 2019, Expert Review of Anticancer Therapy CrossRef
  10. Microscopic venous invasion in patients with pancreatic neuroendocrine tumor as a potential predictor of postoperative recurrence
    Yoshihide Nanno et al, 2016, Pancreatology CrossRef
  11. Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation
    Shoki Sato et al, 2017, Oncotarget CrossRef
  12. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors
    Koji Hontani et al, 2017, Oncotarget CrossRef
  13. Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
    Isabella Reccia et al, 2023, Cancers CrossRef
  14. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery
    Rodrigo Canellas et al, 2018, Journal of Magnetic Resonance Imaging CrossRef
  15. The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia
    Alexandros Pergaris et al, 2023, Cancers CrossRef
  16. Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment
    Lulu Tanno et al, 2022, Neuroendocrinology CrossRef